Investors & Media

Nov 16, 2018 4:02 PM EST

Copyright Nasdaq. Minimum 15 minutes delayed.

Investors & Media

SEC Filing Details

SEC Filing Details

Document Details

Filing Date
Oct 30, 2018
Document Date
Oct 30, 2018
Form Description
Definitive proxy statement relating to merger or acquisition
Filing Group
Mergers & Acquisitions
Company
Keryx Biopharmaceuticals, Inc.
Issuer
KERYX BIOPHARMACEUTICALS INC